More News

Pneumonia can reveal undiagnosed blood cancer

Severe pneumococcal disease requiring hospitalisation, most commonly pneumonia, can be a sign of previously undiagnosed blood cancer and immunodeficiency...

Base to Base biotech podcast 78: A new treatment for erectile dysfunction, and nanotechnology for knee osteoarthritis

This week, we chat with Lucas Decuypere, CEO and president of Allegro, about treatment of knee osteoarthritis with a...

Kovina Therapeutics awarded $2.3m grant for first-in-class HPV cancer therapy

Kovina Therapeutics Inc., a biotech company developing first-in-class small molecule therapeutics targeting the human papillomavirus (HPV) E6 oncoprotein, has...

IL-23 inhibitor shows improvement in spinal pain and stiffness in axial psoriatic arthritis study

Johnson & Johnson has announced that TREMFYA (guselkumab) met the primary and major secondary endpoints demonstrating both improvement in...

Canada looks to biotech as a national priority

BIOTECanada concluded BIONATION 2026 at the National Arts Centre in Ottawa, convening senior biotech and life sciences leaders with...

Starving cancer’s fuel source could boost treatment effectiveness

Targeting how cancer cells adapt and survive in nutrient-deprived environments could slow tumour growth and make existing treatments more...

SOTIO looks to potential best-in-class ADC for sarcoma

SOTIO Biotech has announced that the U.S. Food and Drug Administration has granted SOT106 Orphan Drug Designation for the...

Hidden protein helps cells divide correctly

A previously unknown protein, hidden in RNA thought not to encode proteins, helps cells divide correctly. The RNA molecule...

Base to Base biotech podcast 77: Transferring mammal traits to humans, and a new way to kill cancer?

This week, we chat with Evan Appleton, chief scientific officer and co-founder of Intertwined, a company focused on understanding...

New possibilities for Alzheimer’s treatment by restoring brain immune balance

Minah Suh of the Department of Biomedical Engineering at Sungkyunkwan University, in collaboration with the biotechnology company IMNEWRUN and...

Insilico launches AI-driven longevity vaccines research

Insilico Medicine has launched Longevity Vaccines, a research initiative developing treatments that direct a patient’s own immune cells to...

KAIST finds a way to redirect cell state with single stimulus

A Korean research team has developed a general-purpose computational framework that identifies the key targets needed to steer a...

Sling Therapeutics raises $123m for phase 3 thyroid eye disease study

Sling Therapeutics, Inc., a clinical-stage biopharmaceutical company developing the first and only late-stage oral small-molecule therapy for thyroid eye...

Cracking the genetic code of psoriasis

A research team has revealed the specific mechanisms behind the onset of psoriasis by combining large-scale genomic data from...

FDA approves drug for SMA

Cure SMA, a nonprofit organisation supporting those impacted by spinal muscular atrophy (SMA) has reacted positively to the news...

Big Picture Bio founded to work on promising cancer combination therapies

Big Picture Bio Ltd., has been founded to identify, design and optimise promising cancer combination therapies, using a generative...

Earlier asthma diagnosis could bring relief

Blowing into a tube to diagnose asthma is not easy for babies or toddlers. Babies and young children suspected of...

Stem cells can contribute to new treatments for heart attacks and Parkinson’s

Cells from nine “super donors” are being collected in Oslo. The aim is for these to be used to...

FDA okays IND application for familial adenomatous polyposis drug

Sapience Therapeutics, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted the company an Investigational...

NTDpedia launched to fight neglected tropical diseases

The Global Health Innovative Technology (GHIT) Fund has launched NTDpedia: Your Guide to Neglected Tropical Diseases. Designed as an accessible,...

Base to Base biotech podcast 76: Early disease detection and beating CNS cancers

This week, we have conversations with Marc Hedrick, CEO of Cerenome, about a combined approach to tackling central nervous...